HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ether hydrochloride → (R)-5-[1-(4-Chlorophenethyl)pyrrolidine-3-yl]-5,11-dihydrodibenzo [b,e][1,4]oxazepine Hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ether hydrochloride | HCID 10953452 | — |
| Reactant | (R)-5-[1-(4-chlorophenethyl) pyrrolidine-3-yl]-5,11-dihydrodibenzo[b,e][1,4]oxazepine | HCID 12018624 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | (R)-5-[1-(4-Chlorophenethyl)pyrrolidine-3-yl]-5,11-dihydrodibenzo [b,e][1,4]oxazepine Hydrochloride | HCID 22975055 | — |
Reaction Steps
2.0 ml of 2 M hydrochloric acid/ethyl ether was added to a solution of (R)-5-[1-(4-chlorophenethyl)pyrrolidine-3-yl]-5,11-dihydro-dibenzo[b,e][1,4]oxazepine (44 mg, 0.11 mmol) in dichloromethane, and they were stirred for 1 hour. The solvent was evaporated under reduced pressure to obtain the title compound in the form of a light yellow solid (42 mg, 87%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06528504B2 |
| Source dataset | uspto-grants-2003_03 |
| ORD ID | ord-8180f569c99948e4869feee6ae9e6cb9 |
| Source note | uspto-grants-2003_03 |